Adjuvant Therapy for Resected NSCLC Harboring EGFR Mutation, Chemotherapy or Targeted Therapy - PROs

被引：0
|
作者：
Zhong, W. [1 ,2 ]
机构：
[1] Guangdong Prov Peoples Hosp, Guangdong Lung Canc Inst, Guangzhou, Guangdong, Peoples R China
[2] Guangdong Acad Med Sci, Guangdong Prov Key Lab Translat Med Lung Canc, Guangzhou, Guangdong, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
Adjuvant therapy; EGFR-TKI; Lung cancer; VINORELBINE PLUS CISPLATIN;
D O I：
10.1016/j.jtho.2019.08.292
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PC03.01
引用
收藏
页码：S142 / S142
页数：1
相关论文
共 50 条
  • [21] Which do patients prefer as a first-line therapy, EGFR-TKI or chemotherapy, if they have NSCLC harboring EGFR mutation? A Vignettes study (LOGIK0903).
    Sasaki, Jiichiro
    Tokunaga, Shoji
    Suetsugu, Takayuki
    Ebi, Noriyuki
    Fukuda, Minoru
    Nagata, Nobuhiko
    Takayama, Koichi
    Tsuruta, Nobuko
    Ishida, Masayuki
    Nishida, Chinatsu
    Kashiwabara, Kosuke
    Akamine, Shinji
    Komiya, Kazutoshi
    Nakagaki, Noriaki
    Kishi, Hiroto
    Seto, Takashi
    Saeki, Sho
    Uchitomi, Yosuke
    Ichinose, Yukito
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [22] Patient-Reported Outcomes from ADAURA: Osimertinib as Adjuvant Therapy in Patients with Resected EGFR Mutated (EGFRm) NSCLC
    Majem, M.
    Goldman, J.
    John, T.
    Grohe, C.
    Laktionov, K. K.
    Kim, S.
    Kato, T.
    Vu, H. V.
    Lu, S.
    Lee, K. Y.
    Akewanlop, C.
    Yu, C.
    De Marinis, F.
    Bonanno, L.
    Domine, M.
    Shepherd, F.
    Zeng, L.
    Kulkarni, D.
    Medic, N.
    Tsuboi, M.
    Herbst, R.
    Wu, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S112 - S113
  • [23] Targeted Therapy for EGFR Positive Mutant NSCLC with CNS Metastasis
    Ahn, M.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1700 - S1701
  • [24] Systemic Therapy for Oligoprogression in Patients with Metastatic NSCLC Harboring Activating EGFR Mutations
    Rossi, Antonio
    Galetta, Domenico
    CANCERS, 2022, 14 (03)
  • [25] ESTIMATING SURVIVAL AFTER ADJUVANT CHEMOTHERAPY FOR RESECTED NSCLC
    McCaughan, G.
    Blinman, P.
    Boyer, M.
    Stockler, M.
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (03) : S31 - S31
  • [26] Comparison of first-generation EGFR-TKIs (gefitinib, erlotinib, and icotinib) as adjuvant therapy in resected NSCLC patients with sensitive EGFR mutations
    Liang, W.
    He, Q.
    Li, C.
    Liang, H.
    Cheng, B.
    He, J.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (04) : S732 - S732
  • [27] Comparison of first-generation EGFR-TKIs (gefitinib, erlotinib, and icotinib) as adjuvant therapy in resected NSCLC patients with sensitive EGFR mutations
    He, Qihua
    Liu, Jun
    Cai, Xiuyu
    Li, Caichen
    Liang, Hengrui
    Cheng, Bo
    Xia, Xiaojun
    Guo, Minzhang
    Liang, Peng
    Zhong, Ran
    Li, Feng
    Yu, Ziwen
    Zhao, Yi
    Ou, Limin
    Xiong, Shan
    Li, Jianfu
    Zhang, Jianrong
    He, Jianxing
    Liang, Wenhua
    TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (11) : 4120 - +
  • [28] A single institution experience of adjuvant chemotherapy for resected NSCLC
    Taylor, P.
    Benrajab, A.
    Summers, Y.
    Bishop, P.
    Shah, R.
    Thatcher, N.
    LUNG CANCER, 2010, 67 : S8 - S8
  • [29] Upfront Radiation Therapy with TKI Improved the Intracranial PFS but Not OS in the NSCLC Patients Harboring EGFR Mutation and Brain Metastases
    Wang, C.
    Lu, X.
    Zhou, Z.
    Bi, N.
    Wang, J.
    Hui, Z.
    Liang, J.
    Feng, Q.
    Chen, D.
    Xiao, Z.
    Lv, J.
    Wang, X.
    Wang, X.
    Zhang, T.
    Deng, L.
    Wang, W.
    Xiao, J.
    Li, J.
    Wang, L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : S232 - S232
  • [30] Promising efficacy as combination therapy of DFP-14323, protease inhibitor, with EGFR-TKI in patients with metastatic NSCLC harboring EGFR mutation
    Yoshioka, H.
    Mori, M.
    Katakami, N.
    Yokoyama, T.
    Kaneda, H.
    Hirano, K.
    Kumagai, T.
    Huang, C-L.
    ANNALS OF ONCOLOGY, 2020, 31 : S1401 - S1401
12345